Operational efficiency remains high, evidenced by a 1.72x OCF/NI conversion ratio in 2025Q4, which supports the company's ability to fund shareholder returns.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 220.16M | 216.56M | 182M | 183.76M | 138.54M | 160.51M | 150.49M | 124.46M | 118.7M | 110.62M | 107.61M | 103.83M | 85.35M | 55.69M | 53.78M | 44.9M | 39.03M | 48.07M | 22.9M | 15.64M | 16.37M | 13.7M | 12.14M | 11.15M | 10.11M | 3.22M | 5.95M | 4.7M | 3.9M | 3M | 3.6M |
| Operating CF Margin % | - | 20.88% | 19.08% | 19.92% | 14.7% | 20.09% | 21.39% | 19.34% | 18.44% | 18.6% | 19.45% | 18.79% | 15.77% | 16.52% | 17.33% | 15.38% | 15.3% | 21.91% | 9.87% | 8.87% | 16.22% | 1.63% | 18.02% | 18.03% | 16.8% | 6.98% | 17.93% | 15.82% | 13.59% | 10.49% | 13.64% |
| Operating CF Growth % | 71.32% | 18.99% | -0.96% | 32.64% | -13.69% | 6.66% | 20.92% | 4.86% | 7.3% | 2.79% | 3.65% | 21.65% | 53.25% | 3.55% | 19.77% | 15.04% | -18.81% | 109.95% | 46.43% | -4.48% | 19.51% | 12.79% | 8.89% | 10.27% | 213.9% | -45.88% | 26.66% | 20.51% | 30% | -16.67% | 125% |
| Net Income | 158.08M | 154.84M | 128.47M | 108.54M | 105.37M | 96.1M | 84.62M | 79.67M | 78.57M | 90.07M | 55.97M | 59.72M | 52.83M | 44.87M | 40.01M | 38.77M | 33.28M | 26.79M | 19.05M | 16.12M | 12.28M | 10.95M | 8.03M | 5.64M | 7.42M | 5.11M | 3.73M | 3.1M | 3M | 2.8M | 1.9M |
| Depreciation & Amortization | 47.17M | 45.69M | 47.97M | 54.94M | 51.85M | 48.88M | 51.28M | 45.86M | 44.67M | 44.38M | 46.2M | 39.96M | 30.52M | 10.47M | 9.64M | 9.29M | 8.56M | 8.13M | 7.79M | 6.38M | 3.44M | 2.81M | 3.27M | 3.52M | 2.92M | 2.62M | 2.02M | 2M | 1.7M | 1.1M | 1.4M |
| Stock-Based Compensation | 19.6M | 18.06M | 16.68M | 16.05M | 13.22M | 10.8M | 8.3M | 7.6M | 6.41M | 6.26M | 7.02M | 6.83M | 4.56M | 3.82M | 4.22M | 3.69M | 3.99M | 3.08M | 0 | 1.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 115K | 6.26M | -6.78M | -10.81M | -8.36M | -5.94M | -4.63M | -3.56M | -5.4M | -28.78M | -6.88M | -2.86M | -11.26M | -315K | -92K | 307K | -669K | -1.22M | -238K | -617K | 104K | 599K | 1.39M | 598K | 1.02M | 112K | -168K | -100K | 100K | 0 | -100K |
| Other Non-Cash Items | -20.12M | -835K | 1.77M | -4.96M | 1.68M | -257K | 2.38M | -146K | -1.54M | 663K | 562K | 273K | 493K | 92K | 145K | 682K | -439K | 763K | 2.82M | 199K | 1.44M | 470K | 586K | 309K | 458K | 501K | 299K | 200K | 100K | 200K | 100K |
| Working Capital Changes | 15.31M | -7.46M | -6.12M | 20.01M | -25.22M | 10.93M | 8.53M | -4.96M | -4.01M | -1.98M | 4.73M | -105K | 8.21M | -3.25M | -134K | -7.83M | -5.69M | 10.53M | -6.55M | -8.07M | -897K | -1.13M | -1.13M | 1.08M | -1.69M | -5.12M | 78K | -500K | -1M | -1.1M | 300K |
| Change in Receivables | 10.07M | -20.85M | 5.58M | 6.97M | -3.62M | -20.7M | -3.6M | 11.62M | -7.77M | -3.91M | -15.66M | 10.81M | -8.39M | 2.96M | -7.64M | -2.7M | -2.74M | 862K | 0 | -15.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 12.9M | 3.63M | -22.79M | 10.53M | -7.8M | -21.02M | 13.92M | -11.4M | -6.02M | -319K | 4.75M | 3.13M | 6.7M | -3.94M | -1.98M | -3.01M | -1.86M | 2.66M | -974K | 481K | -827K | -1.5M | -358K | 1.28M | -1.66M | -3.02M | 194K | 100K | -400K | -600K | 0 |
| Change in Payables | 737K | 11.29M | 9.06M | 3.55M | -15.54M | 46.19M | -3.85M | 1.13M | 5.99M | 1.51M | 17.84M | -15.72M | 7.75M | -2.77M | 5.78M | -2.52M | -1.4M | 6.82M | 0 | 7.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -44.27M | -43.89M | -59.74M | -34.81M | -416.01M | -35.3M | -34.59M | -156.22M | -31.99M | -42.7M | -133.59M | -42.28M | -504.42M | -8.38M | -14M | -6.61M | -11.05M | -3.64M | -5.56M | -45.77M | -25.23M | -12.94M | -1.23M | -2.31M | -9.95M | -16.35M | -956K | -700K | -5.7M | -1.8M | -2.3M |
| Capital Expenditures | 5.56M | -43.49M | -35.66M | -37.89M | -50.29M | -37.45M | -33.83M | -28.41M | -19.72M | -28.09M | -23.99M | -42.31M | -13.37M | -8.42M | -14M | -6.64M | -7.56M | -3.64M | -5.26M | -5.04M | -2.36M | -1.77M | -1.22M | -2.27M | -10.02M | -1.95M | -881K | -600K | -1.6M | -1.1M | -1M |
| CapEx % of Revenue | 0.53% | 4.19% | 3.74% | 4.11% | 5.34% | 4.69% | 4.81% | 4.41% | 3.06% | 4.72% | 4.34% | 7.66% | 2.47% | 2.5% | 4.51% | 2.27% | 2.96% | 1.66% | 2.27% | 2.86% | 2.34% | 0.21% | 1.8% | 3.67% | 16.65% | 4.23% | 2.65% | 2.02% | 5.57% | 3.85% | 3.79% |
| Acquisitions | 0 | -49K | -24.16M | -1.54M | -365.78M | 318K | 87K | -141.06M | -17.4M | -17.39M | -110.6M | 34K | -491.06M | 0 | 0 | 0 | -4.66M | 0 | -296K | -40.74M | -22.87M | -11.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -49.86M | 0 | 89K | 1.88M | 56K | 1.83M | -850K | 13.25M | 5.13M | 2.79M | 1M | 34K | -168K | 40K | -121K | 28K | 1.17M | 0 | 0 | 11K | 0 | 245K | -14K | -44K | 69K | -14.4M | -75K | -100K | -4.1M | 500K | -1.3M |
| Cash from Financing | -155.62M | -152.81M | -133.81M | -153.32M | 246.68M | -102.18M | -101.16M | 43.38M | -71.45M | -68.63M | -19.45M | -25.84M | 261.67M | 16.46M | -9.84M | -632K | 3.18M | -1.53M | -16.12M | 27.09M | 1.05M | -493K | -7.42M | -1.33M | -1.55M | 13.18M | -3.63M | -3.6M | 2.4M | -500K | -1.4M |
| Debt Issued (Net) | 1K | -26.19M | -119.78M | -131.22M | 300.83M | -55.16M | -85.15M | 75M | -63.52M | -64.38M | -16.88M | -35M | 256.86M | 0 | -1.21M | -3.56M | -1.36M | -4.8M | -15.87M | 26.79M | 0 | 0 | -9.58M | -1.74M | -1.74M | 13.06M | -1.25M | -2.5M | 2.2M | -600K | -1.4M |
| Equity Issued (Net) | -102.31M | -98.33M | -5.68M | -4.47M | -35.42M | -35.24M | -13.46M | -21.32M | -1.39M | -1.91M | 5.6M | 11.4M | -1.07M | -1.93M | 206K | 4.34M | -937K | 0 | 1.05M | 1.22M | 1.24M | 211K | 2.56M | 807K | 515K | 511K | -2.06M | -900K | 300K | 200K | 0 |
| Dividends Paid | -30.79M | -28.29M | -25.58M | -22.87M | -20.71M | -18.72M | -16.7M | -15.13M | -13.43M | -12.07M | -10.72M | -9.25M | -7.86M | 0 | -11.7M | -4.31M | -3.09M | -2.01M | -1.98M | -1.6M | -1.04M | -685K | -389K | -382K | -305K | -277K | -245K | -200K | -200K | -100K | -100K |
| Share Repurchases | -118M | -107.64M | -5.68M | -4.47M | -35.42M | -35.24M | -13.46M | -21.32M | -1.39M | -1.91M | -1.59M | -1.21M | -1.07M | -1.93M | -1.7M | -109K | -937K | 0 | 0 | 0 | 0 | -1.2M | 0 | 0 | 0 | 0 | -2.24M | -900K | 0 | 0 | 0 |
| Other Financing | -22.57M | 0 | 17.23M | 5.24M | 1.98M | 6.94M | 14.15M | 4.84M | 6.9M | 9.73M | 2.55M | 7.01M | 13.73M | 18.39M | 2.86M | 2.89M | 8.57M | 5.28M | 672K | 677K | 861K | -19K | -14K | -14K | -20K | -123K | -71K | 0 | 100K | 0 | 100K |
| Net Change in Cash | 22.97M | 25.05M | -14.93M | -2.11M | -36.68M | 18.67M | 18.9M | 11.4M | 13.85M | 1.77M | -46.15M | 34.51M | -158.46M | 64.01M | 29.96M | 37.53M | 30.82M | 43.01M | 1.11M | -2.88M | -7.81M | 262K | 3.5M | 7.51M | -1.39M | 52K | 1.37M | 400K | 600K | 700K | -100K |
| Free Cash Flow | 182.23M | 173.07M | 146.34M | 145.87M | 88.25M | 123.06M | 116.67M | 96.05M | 98.97M | 82.52M | 83.62M | 61.52M | 71.98M | 47.27M | 39.78M | 38.27M | 31.47M | 44.43M | 17.64M | 10.6M | 14.01M | 11.93M | 10.93M | 8.88M | 94K | 1.27M | 5.07M | 4.1M | 2.3M | 1.9M | 2.6M |
| FCF Margin % | 17.23% | 16.69% | 15.34% | 15.81% | 9.36% | 15.4% | 16.58% | 14.92% | 15.38% | 13.87% | 15.12% | 11.13% | 13.3% | 14.02% | 12.81% | 13.11% | 12.34% | 20.25% | 7.6% | 6.01% | 13.88% | 1.42% | 16.22% | 14.36% | 0.16% | 2.76% | 15.28% | 13.8% | 8.01% | 6.64% | 9.85% |
| FCF Growth % | 20.88% | 18.27% | 0.32% | 65.3% | -28.29% | 5.48% | 21.47% | -2.96% | 19.93% | -1.31% | 35.93% | -14.54% | 52.26% | 18.85% | 3.95% | 21.58% | -29.16% | 151.93% | 66.43% | -24.37% | 17.44% | 9.14% | 23.04% | 9350% | -92.61% | -74.92% | 23.71% | 78.26% | 21.05% | -26.92% | 420% |
| FCF per Share | 5.64 | 5.31 | 4.47 | 4.50 | 2.72 | 3.77 | 3.59 | 2.95 | 3.05 | 2.56 | 2.62 | 1.94 | 2.31 | 1.53 | 1.31 | 1.27 | 1.06 | 1.54 | 0.62 | 0.38 | 0.51 | 0.44 | 0.42 | 0.35 | 0.00 | 0.05 | 0.21 | 0.16 | 0.09 | 0.08 | 0.11 |
| FCF Conversion (FCF/Net Income) | 1.15x | 1.40x | 1.42x | 1.69x | 1.31x | 1.67x | 1.78x | 1.56x | 1.51x | 1.23x | 1.92x | 1.74x | 1.62x | 1.24x | 1.34x | 1.16x | 1.17x | 1.79x | 1.20x | 0.97x | 1.33x | 1.25x | 1.51x | 1.98x | 1.36x | 0.63x | 1.60x | 1.52x | 1.30x | 1.07x | 1.89x |
| Interest Paid | 7.59M | 10.6M | 17.7M | 25.93M | 11.88M | 4.55M | 4.67M | 0 | 6.94M | 7.02M | 6.67M | 5.99M | 4.68M | 40K | 6K | 84K | 111K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 36.31M | 37.75M | 42.64M | 35.73M | 33.02M | 25.36M | 22.64M | 0 | 20.59M | 25.84M | 30.74M | 19.55M | 25.3M | 12.1M | 14.84M | 17.66M | 17.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ethylene Oxide Regulatory Exposure
Based on reported financial data, Balchem consistently demonstrates strong cash conversion, with the OCF/NI ratio frequently exceeding 1.0, as evidenced by the 1.72x conversion rate recorded in 2025Q4, suggesting that reported net income is well-supported by actual cash generation from core operations.
The consistent ability to generate operating cash flow in excess of net income indicates a high quality of earnings, largely devoid of aggressive accrual accounting. Investors should monitor whether this trend persists as the company navigates potential regulatory-driven capital expenditure requirements.
As reported in recent quarterly filings, Balchem maintains a resilient free cash flow trajectory, with margins peaking at 24.4% in 2023Q4, which underscores the company's ability to convert its specialized chemical revenue into significant liquidity despite periodic fluctuations in working capital requirements.
The stability of these margins suggests that the company's business model is inherently cash-generative and less capital-intensive than traditional commodity chemical peers. This trajectory provides management with the flexibility to pursue tuck-in acquisitions without relying on external debt financing.
According to historical cash flow statements, Balchem exhibits a disciplined approach to capital intensity, with CapEx/Revenue ratios remaining largely in the low-to-mid single digits, such as the 2.2% observed in 2025Q1, reflecting a focus on maintenance rather than aggressive capacity expansion.
This low capital intensity is a hallmark of the company's niche market positioning, where intellectual property and regulatory barriers provide the primary competitive moat. Future increases in this ratio may indicate necessary investments in emission control technologies to comply with evolving environmental standards.
Based on the provided cash flow data, Balchem experiences notable swings in working capital, including a significant $32.5 million inflow in 2023Q4 followed by a $15.3 million outflow in 2025Q1, which suggests that inventory and receivables management remains sensitive to seasonal or cyclical demand shifts.
These fluctuations appear to be a byproduct of the company's supply chain complexity and the timing of large-scale sterilization canister shipments. Analysts should interpret these movements as operational noise rather than a fundamental deterioration in the company's ability to collect cash from its customer base.
As indicated by recent financial statements, Balchem utilizes its robust cash flow primarily for shareholder returns and strategic tuck-in acquisitions, with share repurchases totaling $53.6 million in 2025Q4, highlighting a management philosophy that prioritizes capital return over aggressive balance sheet expansion.
The company's reliance on internal cash to fund both dividends and buybacks reinforces its fortress balance sheet status. This approach suggests that management remains cautious regarding large-scale M&A, preferring to maintain liquidity for potential regulatory contingencies or smaller, high-return intellectual property acquisitions.
Quick answers to the most common questions about buying BCPC stock.
Balchem Corporation (BCPC) generated $216.6M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Balchem Corporation (BCPC) generated $173.1M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Balchem Corporation (BCPC) spent $43.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Balchem Corporation (BCPC) returned $28.3M to shareholders via cash dividends and spent $107.6M on share repurchases. This shows the company's commitment to returning capital to its equity investors.